Works matching IS 14248247 AND DT 2020 AND VI 13 AND IP 11


Results: 90
    1

    Logic Gates Based on DNA Aptamers.

    Published in:
    Pharmaceuticals (14248247), 2020, v. 13, n. 11, p. 417, doi. 10.3390/ph13110417
    By:
    • Andrianova, Mariia;
    • Kuznetsov, Alexander
    Publication type:
    Article
    2
    3
    4

    Secretory Phospholipase A 2 -IIA Protein and mRNA Pools in Extracellular Vesicles of Bronchoalveolar Lavage Fluid from Patients with Early Acute Respiratory Distress Syndrome: A New Perception in the Dissemination of Inflammation?

    Published in:
    Pharmaceuticals (14248247), 2020, v. 13, n. 11, p. 415, doi. 10.3390/ph13110415
    By:
    • Papadopoulos, Stylianos;
    • Kazepidou, Eleftheria;
    • Antonelou, Marianna H.;
    • Leondaritis, George;
    • Tsapinou, Alexia;
    • Koulouras, Vasilios P.;
    • Avgeropoulos, Apostolos;
    • Nakos, George;
    • Lekka, Marilena E.
    Publication type:
    Article
    5
    6
    7
    8
    9

    VEGF-Related Germinal Polymorphisms May Identify a Subgroup of Breast Cancer Patients with Favorable Outcome under Bevacizumab-Based Therapy—A Message from COMET, a French Unicancer Multicentric Study.

    Published in:
    Pharmaceuticals (14248247), 2020, v. 13, n. 11, p. 414, doi. 10.3390/ph13110414
    By:
    • Gal, Jocelyn;
    • Milano, Gérard;
    • Brest, Patrick;
    • Ebran, Nathalie;
    • Gilhodes, Julia;
    • Llorca, Laurence;
    • Dubot, Coraline;
    • Romieu, Gilles;
    • Desmoulins, Isabelle;
    • Brain, Etienne;
    • Goncalves, Anthony;
    • Ferrero, Jean-Marc;
    • Cottu, Paul-Henri;
    • Debled, Marc;
    • Tredan, Olivier;
    • Chamorey, Emmanuel;
    • Merlano, Marco Carlo;
    • Lemonnier, Jérôme;
    • Etienne-Grimaldi, Marie-Christine;
    • Pierga, Jean-Yves
    Publication type:
    Article
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28
    29
    30
    31
    32
    33
    34
    35
    36
    37
    38
    39
    40
    41
    42
    43
    44
    45
    46
    47

    Later-Line Treatment with Lorlatinib in ALK - and ROS1 -Rearrangement-Positive NSCLC: A Retrospective, Multicenter Analysis.

    Published in:
    Pharmaceuticals (14248247), 2020, v. 13, n. 11, p. 371, doi. 10.3390/ph13110371
    By:
    • Hochmair, Maximilian J.;
    • Fabikan, Hannah;
    • Illini, Oliver;
    • Weinlinger, Christoph;
    • Setinek, Ulrike;
    • Krenbek, Dagmar;
    • Prosch, Helmut;
    • Rauter, Markus;
    • Schumacher, Michael;
    • Wöll, Ewald;
    • Wass, Romana;
    • Brehm, Elmar;
    • Absenger, Gudrun;
    • Bundalo, Tatjana;
    • Errhalt, Peter;
    • Urban, Matthias;
    • Valipour, Arschang
    Publication type:
    Article
    48
    49
    50